Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

Arsenal Biosciences, Inc. · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
cell-therapyrecurrence
advanced/metastatic clear cell renal cell carcinoma, recurrence, kidney cancer, car t, cell therapy, autologous, autologous cell therapy, ccrcc, clear cell renal cell carcinoma, ab-2100, integrated circuit t cell, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 885749
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.